logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

Dennis Bourdette

Oregon Health & Science University

67H-index
370Paper Count
1.7WCitation Count
Published Papers 101
Publication Date
logo
Implementation of a pilot online educational program to identify paramagnetic rim lesions
errMultiple Sclerosis Journal
IF5
err2026-08-22
err0
PREAI
errRicha Thakkar; Elizabeth Silbermann; Francesca Bagnato; Dennis Bourdette; Christopher C. Hemond; William Rooney; Andrew J. Solomon; Lindsey Wooliscroft; Chris Hollen
errShare
errSave
Stop the Spin: Confronting Reporting Bias in Multiple Sclerosis Research
errAnnals of Neurology
IF7.7
err2026-01-26
err0
PREAI
errDennis Bourdette MD; Elizabeth Silbermann MD
errShare
errSave
Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program
errNEUROLOGY-CLINICAL PRACTICE
IF3.2
err2025-02-01
err0
PREAI
errHartung, Daniel M.; Markwardt, Sheila; Bourdette, Dennis
errShare
errSave
Investigating When Patients With Multiple Sclerosis Should Switch From a Low- or Moderate-Efficacy Therapy to a High-Efficacy Treatment
errNEUROLOGY
IF8.5
err2024-09-24
err0
PREAI
errBourdette, Dennis
errShare
errSave
Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
errNEUROTHERAPEUTICS
IF6.9
err2024-07-01
err0
errOAAI
errBourdette, Dennis; Wooliscroft, Lindsey
errShare
errSave
The Challenges of Treating Late-Onset Multiple Sclerosis
errNEUROLOGY
IF8.5
err2024-03-26
err0
PREAI
errBourdette, Dennis; Wooliscroft, Lindsey
errShare
errSave
Rituximab for Multiple Sclerosis Hiding in Plain Sight
errNEUROLOGY
IF8.5
err2024-01-23
err3
errOAAI
errLanger-Gould, Annette; Sotirchos, Elias S.; Bourdette, Dennis
errShare
errSave
What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?
errNEUROLOGY
IF8.5
err2023-11-14
err2
PREAI
errBourdette, Dennis; Silbermann, Elizabeth
errShare
errSave
Polypharmacy in multiple sclerosis: More is not necessarily better
errMULTIPLE SCLEROSIS JOURNAL
IF5
err2022-10-14
err5
PREAI
errBourdette, Dennis; Herink, Megan
errShare
errSave
Better Patient Outcomes at Less Cost: An Effective Strategy for Neurology Care
errANNALS OF NEUROLOGY
IF7.7
err2022-06-11
err0
PREAI
errVickrey, Barbara G.; Bourdette, Dennis
errShare
errSave
Accelerating Clinical Trials of New Therapies for Progressive Multiple Sclerosis Thinking Anew
errNEUROLOGY
IF8.5
err2022-05-03
err0
PREAI
errBourdette, Dennis; Sormani, Maria Pia
errShare
errSave
Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program
errNEUROLOGY-CLINICAL PRACTICE
IF3.2
err2022-02-01
err0
errOAAI
errHartung, Daniel M.; Johnston, Kirbee A.; McGregor, Jessina C.; Bourdette, Dennis N.
errShare
errSave
TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor
errCELL CHEMICAL BIOLOGY
IF7.2
err2022-02-01
err15
errOAAI
errFerrara, Skylar J.; Chaudhary, Priya; DeBell, Margaret J.; Marracci, Gail; Miller, Hannah; Calkins, Evan; Pocius, Edvinas; Napier, Brooke A.; Emery, Ben; Bourdette, Dennis; Scanlan, Thomas S.
errShare
errSave
Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis
errNEUROLOGY
IF8.5
err2021-10-19
err0
PREAI
errYeh, E. Ann; Bourdette, Dennis; Wiendl, Heinz
errShare
errSave
Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs
errNEUROLOGY-CLINICAL PRACTICE
IF3.2
err2021-08-01
err8
errOAAI
errHartung, Daniel M.; Johnston, Kirbee A.; Bourdette, Dennis N.; Chen, Randi; Tseng, Chien-Wen
errShare
errSave
Quelling Public Fears About Guillain-Barre Syndrome and COVID-19 Vaccination
errNEUROLOGY
IF8.5
err2021-06-01
err7
PREAI
errBourdette, Dennis; Killestein, Joep
errShare
errSave
Myelin-specific T cells in animals with Japanese macaque encephalomyelitis
errANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
IF3.9
err2021-01-13
err6
errOAAI
errGovindan, Aparna N.; Fitzpatrick, Kristin S.; Manoharan, Minsha; Tagge, Ian; Kohama, Steven G.; Ferguson, Betsy; Peterson, Samuel M.; Wong, Grayson S.; Rooney, William D.; Park, Byung; Axthelm, Michael K.; Bourdette, Dennis N.; Sherman, Larry S.; Wong, Scott W.
errShare
errSave
Two decades of research Time to incorporate comorbidity management into the care of MS?
errNEUROLOGY
IF8.5
err2020-08-04
err1
PREAI
errNelson, Lorene M.; Bourdette, Dennis
errShare
errSave
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic
errNEUROLOGY
IF8.5
err2020-06-02
err140
PREAI
errBrownlee, Wallace; Bourdette, Dennis; Broadley, Simon; Killestein, Joep; Ciccarelli, Olga
errShare
errSave
Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis
errNEUROLOGY
IF8.5
err2020-03-31
err12
PREAI
errHartung, Daniel M.; Johnston, Kirbee A.; Geddes, Jonah; Bourdette, Dennis N.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
D
David Reich
H-index: 141 · Papers: 514
J
Josep Dalmau
H-index: 134 · Papers: 900
J
Jonathan L. Haines
H-index: 128 · Papers: 1.1K
J
Jeffrey Kaye
H-index: 123 · Papers: 936
X
Xinbo Zhang
H-index: 123 · Papers: 688
View more